These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20869630)

  • 1. Female-biased incidence of experimental autoimmune encephalomyelitis reflects sexually dimorphic expression of surface CTLA-4 (CD152) on T lymphocytes.
    Luna RM; Körmendy D; Brunner-Weinzierl MC
    Gend Med; 2010 Aug; 7(4):296-308. PubMed ID: 20869630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.
    Perrin PJ; Maldonado JH; Davis TA; June CH; Racke MK
    J Immunol; 1996 Aug; 157(4):1333-6. PubMed ID: 8759711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
    Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex- and species-specific contribution of CD99 to T cell costimulation during multiple sclerosis.
    Winschel I; Willing A; Engler JB; Walkenhorst M; Meurs N; Binkle-Ladisch L; Woo MS; Pfeffer LK; Sonner JK; Borgmeyer U; Hagen SH; Grünhagel B; Claussen JM; Altfeld M; Friese MA
    Biol Sex Differ; 2024 May; 15(1):41. PubMed ID: 38750588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice.
    Hurwitz AA; Sullivan TJ; Sobel RA; Allison JP
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3013-7. PubMed ID: 11867713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.
    Piganelli JD; Poulin M; Martin T; Allison JP; Haskins K
    J Autoimmun; 2000 Mar; 14(2):123-31. PubMed ID: 10677243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.
    Perrin PJ; Lovett-Racke A; Phillips SM; Racke MK
    Histol Histopathol; 1999 Oct; 14(4):1269-76. PubMed ID: 10506942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells.
    Hoff H; Knieke K; Cabail Z; Hirseland H; Vratsanos G; Burmester GR; Jorch G; Nadler SG; Bröker B; Hebel K; Brunner-Weinzierl MC
    J Immunol; 2009 May; 182(9):5342-51. PubMed ID: 19380781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.
    Verhagen J; Genolet R; Britton GJ; Stevenson BJ; Sabatos-Peyton CA; Dyson J; Luescher IF; Wraith DC
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):E221-30. PubMed ID: 23267099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
    Nikcevich KM; Gordon KB; Tan L; Hurst SD; Kroepfl JF; Gardinier M; Barrett TA; Miller SD
    J Immunol; 1997 Jan; 158(2):614-21. PubMed ID: 8992975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.
    Issazadeh S; Navikas V; Schaub M; Sayegh M; Khoury S
    J Immunol; 1998 Aug; 161(3):1104-12. PubMed ID: 9686568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.
    Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
    Int Immunol; 1999 Dec; 11(12):1889-96. PubMed ID: 10590254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.
    Karandikar NJ; Eagar TN; Vanderlugt CL; Bluestone JA; Miller SD
    J Neuroimmunol; 2000 Sep; 109(2):173-80. PubMed ID: 10996219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4: a negative regulator of autoimmune disease.
    Karandikar NJ; Vanderlugt CL; Walunas TL; Miller SD; Bluestone JA
    J Exp Med; 1996 Aug; 184(2):783-8. PubMed ID: 8760834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
    Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
    Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.